Andrew L. Kung

An accomplished physician, researcher, leader, and mentor, Dr. Kung is an internationally recognized physician-scientist with a special interest in identifying new targets and developing new treatments for childhood cancer. His translational oncology research has been powered by diverse experimental approaches including genomics, molecular biology, cell biology, drug development, and experimental therapeutics. As Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK), Dr. Kung also maintains a clinical practice within the Stem Cell Transplantation Program in addition to leading expansion of the clinical program and heading a program of laboratory-based research. His laboratories use whole-genome sequencing and integrative analysis to identify genetically encoded and non-oncogene vulnerabilities in pediatric cancers. He also continues to search for epigenetic vulnerabilities in a variety of cancer types.